Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells

BACKGROUND: Drug resistance is frequently found in estrogen receptor–positive (ER(+)) breast cancer patients during and after prolonged tamoxifen treatment. Although tamoxifen rechallenge has been proposed for treating recurrent breast tumors, the clinical benefit of this treatment is still controve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yung-Chieh, Cheung, Chun Hei Antonio, Kuo, Yao-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338790/
https://www.ncbi.nlm.nih.gov/pubmed/32695778
http://dx.doi.org/10.3389/fcell.2020.00485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338790/
https://www.ncbi.nlm.nih.gov/pubmed/32695778
http://dx.doi.org/10.3389/fcell.2020.00485

Ejemplares similares